Jennifer P. Nock
Much Ado About “About”
Biosimilars Law Bulletin ·
ITC as a Biosimilar Battleground: Genentech Challenges Biocon’s Pertuzumab Biosimilar
Biosimilars Law Bulletin ·
Breaking the Patent Thicket: Why the Proposed ETHIC Act Could Have Big Implications on Pharma Patent Law
Biosimilars Law Bulletin ·
District Circuit Denies Novartis’s Request for Injunctive Relief Against MSN’s Generic Version of Entresto®
Biosimilars Law Bulletin ·